Saw Palmetto Claims Case Set For November Oral Arguments
This article was originally published in The Tan Sheet
Executive Summary
FDA argues it never violated First Amendment rights of plaintiffs Julian Whitaker et al. when it denied saw palmetto health claims because they were never considered under the health claim provisions of the Dietary Supplement Health & Education Act